Print Page   |   Contact Us   |   Report Abuse   |   Sign In   |   Join HiNZ Sector Updates

Orion Health’s McCrae to take firm private

Thursday, 7 February 2019  
Share |

Orion Health Group’s founder and biggest shareholder, Ian McCrae, is leading a consortium to end the healthcare software developer’s four-year stint as a public company.


Macrae personally holds almost 86 per cent of the outstanding stock and has pooled that stake with other investors, including Compac founder Hamish Kennedy’s 5.3 per cent holding, to make the takeover a certainty by crossing the 90 per cent threshold needed to mop-up the remaining shares.


The new entity – Grafton Health Holdings – will offer $1.224 a share, or $5.9 million, to buy the 7 per cent it doesn’t yet own and will enforce Takeovers Code provisions to do so.


The majority of Orion shareholders took up a share buy-back in December to exit the firm after agreeing to a radical overhaul, in which its profitable Rhapsody business was sold to UK private equity for $205 million. The firm’s holding in the population health management division was also diluted, leaving it with full ownership of the hospitals unit.


The offer price matches the buy-back price, and Grafton will cover brokerage for those who accept. The shares rose 6 per cent to $1.22 and have gained 27 per cent the past year.


Orion independent directors Andrew Ferrier and Paul Shearer have set up a committee to respond to the takeover and will appoint an independent adviser to judge the offer. It recommends shareholders take no action until the board gives further guidance, including the report.


If successful, Grafton will delist Orion, but has no plans to make any material changes to the business or its capital structure.


“However, Grafton reserves the right to make changes in the future, depending on the business and economic environment and other relevant circumstances that arise after the offer,” it said.


McCrae will remain the biggest shareholder of Grafton with about 87 per cent. Kennedy will hold 8.1 per cent and Orion director Michael Falconer’s interests will own about 2.5 per cent.


Orion had been profitable in private ownership but sought to accelerate global growth by raising funds from the public, while also changing to a subscription model from one-off perpetual licensing.


The Kiwi firm had hoped to profit from the previous US administration’s Affordable Healthcare Act, known as Obamacare, which poured billions of federal government dollars into the wider US health sector. However, that flagship policy of Barack Obama’s presidency was strongly opposed by the Republican Party and changes to the law forced many of Orion’s customers to cancel orders when their own funding ran out.


Source: BusinessDesk, 7 February 2019


Sector updates are provided by organisations to and have not necessarily been edited or checked for accuracy. Any queries should be directed to the organisation issuing the release.

Do you have an item to add to sector updates?

Email your information to us at


Return to home page

HiNZ, PO Box 300125, Albany, Auckland 0752, New Zealand.

Membership Management Software Powered by YourMembership  ::  Legal